Home › Funds › GREAT POINT PARTNERS LLC › DBVT
GREAT POINT PARTNERS LLC position in DBVT
DBV TECHNOLOGIES S A · Health Care
GREAT POINT PARTNERS LLC reported holding 156,906 shares of DBVT (DBV TECHNOLOGIES S A) in its Q2 2026 13F filing — a position valued at US$2.6M, representing 0.54% of its reported portfolio and ranking #39 among its reported holdings. GREAT POINT PARTNERS LLC has disclosed DBVT holdings in 3 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How GREAT POINT PARTNERS LLC's DBVT position evolved
GREAT POINT PARTNERS LLC first disclosed a stake in DBVT in Q2 2025 at 374,679 shares (US$3.4M). The position peaked in Q3 2025 at 378,594 shares, worth US$3.8M. Across 3 filings, GREAT POINT PARTNERS LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 156,906 shares valued at US$2.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 374.68K | $3.43M | New |
| Q3 2025 | 378.59K | $3.79M | Add |
| Q2 2026 | 156.91K | $2.57M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DBVT and 13F data
DBVT (DBV TECHNOLOGIES S A) is a Health Care company. 57 other funds we track also report a position in DBVT — the largest reported positions include MPM BioImpact LLC (US$60.1M), Siren, L.L.C. (US$30.5M), Vivo Capital, LLC (US$30.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DBVT
- MPM BioImpact LLC 3.67M sh · $60.13M · Q2 2026
- Siren, L.L.C. 1.86M sh · $30.46M · Q2 2026
- Vivo Capital, LLC 1.84M sh · $30.25M · Q2 2026
- PERCEPTIVE ADVISORS LLC 1.65M sh · $27.11M · Q2 2026
- Logos Global Management LP 915.00K sh · $15.01M · Q2 2026
- Patient Square Capital LP 909.47K sh · $14.92M · Q2 2026
- Octagon Capital Advisors LP 574.20K sh · $9.42M · Q2 2026
- Redmile Group, LLC 410.44K sh · $6.73M · Q2 2026
- Elmind Capital, LP 265.00K sh · $4.35M · Q2 2026
- Ishara Investments LP 184.50K sh · $3.03M · Q2 2026
- Yiheng Capital Management, L.P. 170.14K sh · $2.79M · Q2 2026
More on GREAT POINT PARTNERS LLC
FAQ
How long has GREAT POINT PARTNERS LLC held DBVT?
GREAT POINT PARTNERS LLC has disclosed DBVT holdings in 3 of the last 5 reported quarters, going back to Q2 2025.
What is GREAT POINT PARTNERS LLC's current position in DBVT?
As of Q2 2026, GREAT POINT PARTNERS LLC holds 156.91K shares of DBVT (DBV TECHNOLOGIES S A), valued at $2.57M, representing 0.54% of its reported portfolio and ranking #39.
Has GREAT POINT PARTNERS LLC been buying or selling DBVT?
In the latest 13F filing (Q2 2026), GREAT POINT PARTNERS LLC newly opened its position in DBVT. The position peaked in Q3 2025 at 378.59K shares.
Which other funds hold DBVT?
Other major institutional holders of DBVT include MPM BioImpact LLC, Siren, L.L.C., Vivo Capital, LLC, among 57 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.